Clinical effect of magnesium sulfate combined with low molecular weight heparin in the treatment of fetal intrauterine growth retardation

WANG Haiping

doi:10.19837/j.cnki.ahyf.2020.03.021

PDF(844 KB)

Anhui Journal of Preventive Medicine ›› 2020, Vol. 26 ›› Issue (3) : 234-236. DOI: 10.19837/j.cnki.ahyf.2020.03.021

Clinical effect of magnesium sulfate combined with low molecular weight heparin in the treatment of fetal intrauterine growth retardation

WANG Haiping

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Haiping. Clinical effect of magnesium sulfate combined with low molecular weight heparin in the treatment of fetal intrauterine growth retardation[J]. Anhui Journal of Preventive Medicine. 2020, 26(3): 234-236 https://doi.org/10.19837/j.cnki.ahyf.2020.03.021

References

[1] 黎杨坚,李燕姬,伦妙容.妊娠期血清雌激素和孕激素水平的变化及其与胎儿宫内发育情况的关系[J].实用医技杂志, 2019,26(5):564-565.
[2] 黄珠金.硫酸镁治疗胎儿宫内发育迟缓的临床探讨[J].中国卫生标准管理, 2019, (20):57-58.
[3] 汪萍, 单腾飞.低分子肝素联合硫酸镁治疗胎儿生长受限的临床效果及可行性[J].中国妇幼保健, 2017, 32(17):4171-4173.
[4] 李可,朱大伟,陈建昆.子痫前期发病机制与临床治疗研究进展[J].解放军医学杂志, 2019, 44(5):423-429.
[5] Gudmundsson S,Flo K,Ghosh G,et al.Placental pulsatility index:a new,more sensitive parameter for predicting adverse outcome inpregnancies suspected of fetal growth restriction[J].Acta ObstetGynecol Scand,2017,96(2):216－222.
[6] 李云端,刘伟武,徐秀英,等.影响临床胎儿生长受限的多因素分析及预防措施[J].实用临床医药杂志,2017,21(1):90-93.
[7] 程国梅,张琳瑛,陶贝贝.低分子肝素治疗胎儿生长受限的Meta分析[J].中国妇幼保健,2015,30(27):4755-4758.
[8] 施素然,翁妍艳,黄江萍.低分子肝素联合复方氨基酸治疗胎儿生长受限的效果分析及对胎盘表皮生长因子胎盘生长因子表达的影响[J].中国药物与临床, 2019, 19(16):2782-2783.
[9] 唐媛.低分子肝素联合硫酸镁治疗早发型子痫前期的效果评价[J].当代医药论丛, 2019, 17(10):166-167.
[10] 蒲俊欧.硫酸镁治疗胎儿宫内发育迟缓的临床探讨[J].北方药学,2017,14(1):191.